-
1
-
-
0038701685
-
+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy
-
+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis 2003; 187:1534-1543.
-
(2003)
J Infect Dis
, vol.187
, pp. 1534-1543
-
-
Hunt, P.W.1
Martin, J.N.2
Sinclair, E.3
-
3
-
-
77952571995
-
Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection
-
Neuhaus J, Jacobs DR Jr, Baker JV, et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis 2010; 201:1788-1795.
-
(2010)
J Infect Dis
, vol.201
, pp. 1788-1795
-
-
Neuhaus, J.1
Jacobs Jr., D.R.2
Baker, J.V.3
-
4
-
-
79957940339
-
Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after antiretroviral therapy
-
Burdo TH. Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after antiretroviral therapy. J Infect Dis 2011; 204:154-163.
-
(2011)
J Infect Dis
, vol.204
, pp. 154-163
-
-
Burdo, T.H.1
-
5
-
-
80052882129
-
Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells
-
Lederman MM. Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells. J Infect Dis 2011; 204:1217-1226.
-
(2011)
J Infect Dis
, vol.204
, pp. 1217-1226
-
-
Lederman, M.M.1
-
6
-
-
55949084601
-
Inflammatory and coagulation biomarkers and mortality in patients with HIV infection
-
Kuller LH, Tracy R, Belloso W, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008; 5:e203.
-
(2008)
PLoS Med
, vol.5
-
-
Kuller, L.H.1
Tracy, R.2
Belloso, W.3
-
7
-
-
80055049890
-
Impact of CD8+ T cell activation on CD4+ T cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy
-
Hunt PW, Cao HL, Muzoora C, et al. Impact of CD8+ T cell activation on CD4+ T cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy. AIDS 2011; 25:2123-2131.
-
(2011)
AIDS
, vol.25
, pp. 2123-2131
-
-
Hunt, P.W.1
Cao, H.L.2
Muzoora, C.3
-
8
-
-
79952335046
-
Plasma levels of soluble CD14 independently predict mortality in HIV infection
-
Sandler NG, Wand H, Roque A, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis 2011; 203: 780-790.
-
(2011)
J Infect Dis
, vol.203
, pp. 780-790
-
-
Sandler, N.G.1
Wand, H.2
Roque, A.3
-
9
-
-
79956196632
-
Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death
-
Boulware DR, Hullsiek KH, Puronen CE, et al. Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death. J Infect Dis 2011; 203: 1637-1646.
-
(2011)
J Infect Dis
, vol.203
, pp. 1637-1646
-
-
Boulware, D.R.1
Hullsiek, K.H.2
Puronen, C.E.3
-
10
-
-
79953766478
-
Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV
-
Musselwhite LW, Sheikh V, Norton TD, et al. Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV. AIDS 2011; 25:787-795.
-
(2011)
AIDS
, vol.25
, pp. 787-795
-
-
Musselwhite, L.W.1
Sheikh, V.2
Norton, T.D.3
-
11
-
-
84871234436
-
Inflammation, coagulation and cardiovascular disease in HIV-infected individuals
-
Duprez DA, Neuhaus J, Kuller LH, et al. Inflammation, coagulation and cardiovascular disease in HIV-infected individuals. PLoS One 2012; 7:e44454.
-
(2012)
PLoS One
, vol.7
-
-
Duprez, D.A.1
Neuhaus, J.2
Kuller, L.H.3
-
12
-
-
84873412156
-
Elevations in D-dimer and C-reactive protein are associated with the development of osteonecrosis of the hip in HIV-infected adults
-
Morse CG, Dodd LE, Nghiem K, et al. Elevations in D-dimer and C-reactive protein are associated with the development of osteonecrosis of the hip in HIV-infected adults. AIDS 2013; 27:591-595.
-
(2013)
AIDS
, vol.27
, pp. 591-595
-
-
Morse, C.G.1
Dodd, L.E.2
Nghiem, K.3
-
13
-
-
68349139711
-
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
-
Chomont N, El-Far M, Ancuta P, et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 2009; 15:893-900.
-
(2009)
Nat Med
, vol.15
, pp. 893-900
-
-
Chomont, N.1
El-Far, M.2
Ancuta, P.3
-
15
-
-
84864345953
-
Towards an HIV cure: A global scientific strategy
-
Deeks SG, Autran B, Berkhout B, et al. Towards an HIV cure: a global scientific strategy. Nat Rev Immunol 2012; 12:607-614.
-
(2012)
Nat Rev Immunol
, vol.12
, pp. 607-614
-
-
Deeks, S.G.1
Autran, B.2
Berkhout, B.3
-
16
-
-
77950537810
-
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
-
Buzon MJ, Massanella M, Llibre JM, et al. HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects. Nat Med 2010; 16:460-465.
-
(2010)
Nat Med
, vol.16
, pp. 460-465
-
-
Buzon, M.J.1
Massanella, M.2
Llibre, J.M.3
-
17
-
-
78549245806
-
Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy
-
Yukl SA, Shergill AK, McQuaid K, et al. Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy. AIDS 2010; 24:2451-2460.
-
(2010)
AIDS
, vol.24
, pp. 2451-2460
-
-
Yukl, S.A.1
Shergill, A.K.2
McQuaid, K.3
-
18
-
-
84860345691
-
Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: A randomized 48-week study
-
Llibre JM, Buzon MJ, Massanella M, et al. Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week study. Antivir Ther 2012; 17:355-364.
-
(2012)
Antivir Ther
, vol.17
, pp. 355-364
-
-
Llibre, J.M.1
Buzon, M.J.2
Massanella, M.3
-
19
-
-
84870242082
-
Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV infected HAART-suppressed individuals with poor CD4 T-cell recovery
-
Massanella M, Negredo E, Puig J, et al. Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV infected HAART-suppressed individuals with poor CD4 T-cell recovery. AIDS 2012; 26:2285-2293.
-
(2012)
AIDS
, vol.26
, pp. 2285-2293
-
-
Massanella, M.1
Negredo, E.2
Puig, J.3
-
20
-
-
0034329318
-
Mechanisms of HIV-associated lymphocyte apoptosis
-
Badley AD, Pilon AA, Landay A, Lynch DH. Mechanisms of HIV-associated lymphocyte apoptosis. Blood 2000; 96:2951-2964.
-
(2000)
Blood
, vol.96
, pp. 2951-2964
-
-
Badley, A.D.1
Pilon, A.A.2
Landay, A.3
Lynch, D.H.4
-
21
-
-
77749277080
-
Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy
-
McMahon D, Jones J, Wiegand A, et al. Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy. Clin Infect Dis 2010; 50:912-919.
-
(2010)
Clin Infect Dis
, vol.50
, pp. 912-919
-
-
McMahon, D.1
Jones, J.2
Wiegand, A.3
-
22
-
-
77956856393
-
The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: A randomized controlled trial
-
Gandhi RT, Zheng L, Bosch RJ, et al. The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial. PLoS Med 2010; 7:e1000321.
-
(2010)
PLoS Med
, vol.7
-
-
Gandhi, R.T.1
Zheng, L.2
Bosch, R.J.3
-
24
-
-
85027920222
-
A randomized, controlled trial assessing the effects of raltegravir intensification on endothelial function in treated HIV infection
-
Hatano H, Scherzer R, Wu Y, et al. A randomized, controlled trial assessing the effects of raltegravir intensification on endothelial function in treated HIV infection. J Acquir Immune Defic Syndr 2012; 61:317-325.
-
(2012)
J Acquir Immune Defic Syndr
, vol.61
, pp. 317-325
-
-
Hatano, H.1
Scherzer, R.2
Wu, Y.3
-
26
-
-
0142092389
-
+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy
-
+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 2003; 77:11708-11717.
-
(2003)
J Virol
, vol.77
, pp. 11708-11717
-
-
Guadalupe, M.1
Reay, E.2
Sankaran, S.3
-
27
-
-
4644342929
-
+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract
-
+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200:749-759.
-
(2004)
J Exp Med
, vol.200
, pp. 749-759
-
-
Brenchley, J.M.1
Schacker, T.W.2
Ruff, L.E.3
-
28
-
-
77958083540
-
Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections
-
Estes JD, Harris LD, Klatt NR, et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog 2010; 6:e1001052.
-
(2010)
PLoS Pathog
, vol.6
-
-
Estes, J.D.1
Harris, L.D.2
Klatt, N.R.3
-
29
-
-
41849142985
-
Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut
-
Raffatellu M, Santos RL, Verhoeven DE, et al. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 2008; 14:421-428.
-
(2008)
Nat Med
, vol.14
, pp. 421-428
-
-
Raffatellu, M.1
Santos, R.L.2
Verhoeven, D.E.3
-
30
-
-
33845532053
-
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
-
Brenchley JM. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nature Med 2006; 12:1365-1371.
-
(2006)
Nature Med
, vol.12
, pp. 1365-1371
-
-
Brenchley, J.M.1
-
31
-
-
65649102237
-
Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection
-
Jiang W. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis 2009; 199:1177-1185.
-
(2009)
J Infect Dis
, vol.199
, pp. 1177-1185
-
-
Jiang, W.1
-
32
-
-
75649127335
-
Increased tissue factor expression on circulating monocytes in chronic HIV infection: Relationship to in vivo coagulation and immune activation
-
Funderburg NT, Mayne E, Sieg SF, et al. Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. Blood 2010; 115:161-167.
-
(2010)
Blood
, vol.115
, pp. 161-167
-
-
Funderburg, N.T.1
Mayne, E.2
Sieg, S.F.3
-
33
-
-
84865163472
-
Microbial translocation in HIV infection: Causes, consequences and treatment opportunities
-
Sandler NG, Douek DC. Microbial translocation in HIV infection: causes, consequences and treatment opportunities. Nat Rev Microbiol 2012; 10: 655-666.
-
(2012)
Nat Rev Microbiol
, vol.10
, pp. 655-666
-
-
Sandler, N.G.1
Douek, D.C.2
-
34
-
-
33646265743
-
The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: Mucins, antimicrobial peptides, and microbiota
-
Lievin-Le Moal V, Servin AL. The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin Microbiol Rev 2006; 19:315-337.
-
(2006)
Clin Microbiol Rev
, vol.19
, pp. 315-337
-
-
Lievin-Le Moal, V.1
Servin, A.L.2
-
35
-
-
19544366408
-
Commensal gut bacteria: Mechanisms of immune modulation
-
Kelly D, Conway S, Aminov R. Commensal gut bacteria: mechanisms of immune modulation. Trends Immunol 2005; 26:326-333.
-
(2005)
Trends Immunol
, vol.26
, pp. 326-333
-
-
Kelly, D.1
Conway, S.2
Aminov, R.3
-
36
-
-
22144490199
-
An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system
-
Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005; 122:107-118.
-
(2005)
Cell
, vol.122
, pp. 107-118
-
-
Mazmanian, S.K.1
Liu, C.H.2
Tzianabos, A.O.3
Kasper, D.L.4
-
37
-
-
38949134533
-
Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis
-
Gori A, Tincati C, Rizzardini G, et al. Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis. J Clin Microbiol 2008; 46:757-758.
-
(2008)
J Clin Microbiol
, vol.46
, pp. 757-758
-
-
Gori, A.1
Tincati, C.2
Rizzardini, G.3
-
38
-
-
84455208831
-
Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection
-
Cunningham-Rundles S, Ahrne S, Johann-Liang R, et al. Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection. Nutrients 2011; 3:1042-1070.
-
(2011)
Nutrients
, vol.3
, pp. 1042-1070
-
-
Cunningham-Rundles, S.1
Ahrne, S.2
Johann-Liang, R.3
-
39
-
-
84860390171
-
Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: Results of the 'COPA' pilot randomized trial
-
Gori A, Rizzardini G, Van 't Land B, et al. Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the 'COPA' pilot randomized trial. Mucosal Immunol 2011; 4:554-563.
-
(2011)
Mucosal Immunol
, vol.4
, pp. 554-563
-
-
Gori, A.1
Rizzardini, G.2
Van 'T Land, B.3
-
40
-
-
84873369889
-
Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques
-
[Epub ahead of print]
-
Klatt NR, Canary LA, Sun X, et al. Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques. J Clin Invest 2013. [Epub ahead of print]
-
(2013)
J Clin Invest
-
-
Klatt, N.R.1
Canary, L.A.2
Sun, X.3
-
41
-
-
78049505077
-
Reduction of immune activation with chloroquine therapy during chronic HIV infection
-
Murray SM, Down CM, Boulware DR, et al. Reduction of immune activation with chloroquine therapy during chronic HIV infection. J Virol 2010; 84: 12082-12086.
-
(2010)
J Virol
, vol.84
, pp. 12082-12086
-
-
Murray, S.M.1
Down, C.M.2
Boulware, D.R.3
-
43
-
-
0037108969
-
Persistent abnormalitiesinlymphoid tissues of human immunodeficiency virus-infected patients successfully treated with highly active antiretroviral therapy
-
Schacker TW, Nguyen PL, Martinez E, et al. Persistent abnormalitiesinlymphoid tissues of human immunodeficiency virus-infected patients successfully treated with highly active antiretroviral therapy. J Infect Dis 2002; 186:1092-1097.
-
(2002)
J Infect Dis
, vol.186
, pp. 1092-1097
-
-
Schacker, T.W.1
Nguyen, P.L.2
Martinez, E.3
-
44
-
-
0036801658
-
Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis
-
Schacker TW, Nguyen PL, Beilman GJ, et al. Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis. J Clin Invest 2002; 110:1133-1139.
-
(2002)
J Clin Invest
, vol.110
, pp. 1133-1139
-
-
Schacker, T.W.1
Nguyen, P.L.2
Beilman, G.J.3
-
45
-
-
84857479601
-
Lymphoid tissue damage in HIV-1 infection depletes naive T cells and limits T cell reconstitution after antiretroviral therapy
-
Zeng M, Southern PJ, Reilly CS, et al. Lymphoid tissue damage in HIV-1 infection depletes naive T cells and limits T cell reconstitution after antiretroviral therapy. PLoS Pathog 2012; 8:e1002437.
-
(2012)
PLoS Pathog
, vol.8
-
-
Zeng, M.1
Southern, P.J.2
Reilly, C.S.3
-
46
-
-
84865780223
-
Critical role of CD4 T cells in maintaining lymphoid tissue structure for immune cell homeostasis and reconstitution
-
Zeng M, Paiardini M, Engram JC, et al. Critical role of CD4 T cells in maintaining lymphoid tissue structure for immune cell homeostasis and reconstitution. Blood 2012; 120:1856-1867.
-
(2012)
Blood
, vol.120
, pp. 1856-1867
-
-
Zeng, M.1
Paiardini, M.2
Engram, J.C.3
-
47
-
-
0030727150
-
Survival of mature CD4 T lymphocytes is dependent on major histocompatibility complex class II-expressing dendritic cells
-
Brocker T. Survival of mature CD4 T lymphocytes is dependent on major histocompatibility complex class II-expressing dendritic cells. J Exp Med 1997; 186:1223-1232.
-
(1997)
J Exp Med
, vol.186
, pp. 1223-1232
-
-
Brocker, T.1
-
49
-
-
33846785628
-
Simian immunodeficiency virus-induced lymphatic tissue fibrosis is mediated by transforming growth factor beta 1-positive regulatory T cells and begins in early infection
-
Estes JD, Wietgrefe S, Schacker T, et al. Simian immunodeficiency virus-induced lymphatic tissue fibrosis is mediated by transforming growth factor beta 1-positive regulatory T cells and begins in early infection. J Infect Dis 2007; 195:551-561.
-
(2007)
J Infect Dis
, vol.195
, pp. 551-561
-
-
Estes, J.D.1
Wietgrefe, S.2
Schacker, T.3
-
50
-
-
0028109801
-
Transforming growth factor beta in tissue fibrosis
-
Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994; 331:1286-1292.
-
(1994)
N Engl J Med
, vol.331
, pp. 1286-1292
-
-
Border, W.A.1
Noble, N.A.2
-
51
-
-
0032737429
-
Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients
-
Sharma K, Eltayeb BO, McGowan TA, et al. Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients. Am J Kidney Dis 1999; 34:818-823.
-
(1999)
Am J Kidney Dis
, vol.34
, pp. 818-823
-
-
Sharma, K.1
Eltayeb, B.O.2
McGowan, T.A.3
-
52
-
-
0034687149
-
Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease
-
Brilla CG, Funck RC, Rupp H. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 2000; 102:1388-1393.
-
(2000)
Circulation
, vol.102
, pp. 1388-1393
-
-
Brilla, C.G.1
Funck, R.C.2
Rupp, H.3
-
53
-
-
84867650598
-
Angiotensin converting enzyme inhibitor and HMG-CoA reductase inhibitor as adjunct treatment for persons with HIV infection: A feasibility randomized trial
-
Baker JV, Huppler Hullsiek K, Prosser R, et al. Angiotensin converting enzyme inhibitor and HMG-CoA reductase inhibitor as adjunct treatment for persons with HIV infection: a feasibility randomized trial. PLoS One 2012;7:e46894.
-
(2012)
PLoS One
, vol.7
-
-
Baker, J.V.1
Huppler Hullsiek, K.2
Prosser, R.3
-
54
-
-
80052059246
-
An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: Downregulated immune activation and improved T cell-dependent vaccine responses
-
Pettersen FO, Torheim EA, Dahm AE, et al. An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses. J Virol 2011;85:6557-6566.
-
(2011)
J Virol
, vol.85
, pp. 6557-6566
-
-
Pettersen, F.O.1
Torheim, E.A.2
Dahm, A.E.3
-
55
-
-
79952341800
-
High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: Results of a double-blind randomized placebo controlled clinical trial
-
Ganesan A, Crum-Cianflone N, Higgins J, et al. High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trial. J Infect Dis 2011; 203:756-764.
-
(2011)
J Infect Dis
, vol.203
, pp. 756-764
-
-
Ganesan, A.1
Crum-Cianflone, N.2
Higgins, J.3
-
58
-
-
33748947326
-
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
-
Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006; 443:350-354.
-
(2006)
Nature
, vol.443
, pp. 350-354
-
-
Day, C.L.1
Kaufmann, D.E.2
Kiepiela, P.3
-
59
-
-
62249172189
-
Enhancing SIV-specific immunity in vivo by PD-1 blockade
-
Velu V, Titanji K, Zhu B, et al. Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature 2009; 458:206-210.
-
(2009)
Nature
, vol.458
, pp. 206-210
-
-
Velu, V.1
Titanji, K.2
Zhu, B.3
-
60
-
-
60549087784
-
PD-1 blockade in rhesus macaques: Impact on chronic infection and prophylactic vaccination
-
Finnefrock AC, Tang A, Li F, et al. PD-1 blockade in rhesus macaques: impact on chronic infection and prophylactic vaccination. J Immunol 2009; 182:980-987.
-
(2009)
J Immunol
, vol.182
, pp. 980-987
-
-
Finnefrock, A.C.1
Tang, A.2
Li, F.3
-
61
-
-
84862859820
-
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
-
Topalian SL, Hodi FS, Brahmer JR, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 2012; 366: 2443-2454.
-
(2012)
N Engl J Med
, vol.366
, pp. 2443-2454
-
-
Topalian, S.L.1
Hodi, F.S.2
Brahmer, J.R.3
-
62
-
-
84862903106
-
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
-
Brahmer JR, Tykodi SS, Chow LQM, et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 2012; 366:2455-2465.
-
(2012)
N Engl J Med
, vol.366
, pp. 2455-2465
-
-
Brahmer, J.R.1
Tykodi, S.S.2
Chow, L.Q.M.3
|